The Canadian Medical Association urges the pan-Canadian Pharmaceutical Alliance to invite the federal government and private health insurance industry to participate in its price negotiations for prescription drugs.
The Canadian Medical Association urges the pan-Canadian Pharmaceutical Alliance to invite the federal government and private health insurance industry to participate in its price negotiations for prescription drugs.
CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act
(Vanessa's Law)
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
That the Canadian Medical Association urge appropriate agencies to adopt regulations and/or policies to ensure that warnings about the adverse interaction between alcohol and both prescription and non-prescription products be prominently displayed or distributed wherever alcohol and drugs are sold and/or dispensed.
The Canadian Medical Association supports the position that:
1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and
2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
The Canadian Medical Association supports the position that:
1) a patient should have the right to choose either a generic or a brand-name prescription drug where both alternatives exist; and
2) a physician should have the right to order "no substitution" of a drug product he or she prescribes.
